When abnormal cells are found on the cervix the condition is called dysplasia. Cervical dysplasia is considered to be a pre-cancerous condition, can occur at any age from puberty onward, and is usually found in women between the ages of 25 and 35.
A class III Pap should be biopsied if there is a history of recurrent abnormal Pap smears, if significant risk factors are present, or if the patient has been unresponsive to therapy. If the patient has a class IV Pap, proper treatment of cervical dysplasia involves first ascertaining if carcinoma in situ is present. This can only be determined through biopsy. Patients with carcinoma in situ, or a class V Pap, should undergo conization.
The basic approach is to eliminate all factors known to be associated with cervical dysplasia and to optimize the patient’s nutritional status. In particular, eliminate smoking and oral contraceptive use and supplement with nutrients mentioned below. For those patients who undergo conization, treatment is still necessary since the causes of cervical dysplasia are not treated by this approach. Pap smears should be repeated every one to three months, according to severity.
Lifestyle and nutritional factors that appear to play a prominent role in the etiology of cervical dysplasia and carcinoma include: early age of first intercourse; multiple sexual partners; Herpes simplex type 2 and papilloma viruses (HPV); lower socio-economic class; smoking; oral contraceptive use; and many nutritional factors. All risk factors appear to be closely related, as in other multifactorial diseases.
Animal product consumption should be decreased, particularly animal fats and exogenous estrogens. High-fiber foods should be encouraged.
Risk factors for Cervical Dysplasia
Birth control pills tend to increase the risk of cervical dysplasia.
Total/radical/partial hysterectomy or hysterectomy with one ovary or hysterectomy with both ovaries
Absence of cervical dysplasia
Cervical Dysplasia suggests the following may be present
Cervical Dysplasia can lead to
Recommendations for Cervical Dysplasia
The vaginal depletion pack (or vag pack or vag-pack) has a long history of effective use by naturopathic physicians in the treatment of cervical dysplasia. It is thought to work by promoting the sloughing of the superficial cervical cells, particularly those that are abnormal. It is effective in most cases of minor cervical dysplasia. These packs are available in vaginal suppository form and should be used weekly, or as directed by your doctor, until the Pap normalizes. For most patients, the vaginal depletion pack will accelerate the rate of normalization of the cervix.
MGN-3 in stage II and stage III patients completely resolved the problem. After six months of MGN-3 use, with no other form of treatment, all follow-up exams and tests were normal.
Cervical dysplasia is helped by fasting.
The rapidly dividing cells of the cervix require zinc for replication. With depleted zinc levels in cervical tissue, there are corresponding abnormalities in the cells.
Recent evidence suggests that beta-carotene (in doses of about 25,000 IU per day) and/or vitamin C may reverse or reduce the risk of cervical dysplasia.
Vitamin A can be used at 75,000 IU per day for 2 months or until Pap smear results improve, then 25,000 IU per day as a maintenance dose. The preferred form is water-soluble vitamin A. However, doses of vitamin A over 10,000 IU/day should not be considered if pregnancy is a possibility. Vitamin A injections into the cervix have been used successfully when other methods have failed.
Folic Acid in high doses of 10 to 50mg per day have been used successfully to return Pap smears to normal. Folic acid supplementation has resulted in improvement or normalization of cytological smears in patients with cervical dysplasia in placebo-controlled and clinical studies. As folic acid is the most common vitamin deficiency in the world, and quite common in women who are pregnant or taking oral contraceptives, it is probable that many abnormal cytological smears reflect folate deficiency rather than “true” dysplasia. This is particularly applicable to cases in which patients are taking oral contraceptives.
Recent evidence suggests that beta-carotene and/or vitamin C may reverse or reduce the risk of cervical dysplasia. Inadequate vitamin C intake is an independent risk factor for the development of premalignant cervical disease and carcinoma in situ.
|Weak or unproven link|
|Strong or generally accepted link|
|Proven definite or direct link|
|Very strongly or absolutely counter-indicative|
|May do some good|
|Likely to help|
The lower part of the uterus that opens into the vagina.
Abnormal development of tissue.
Abnormal cells on the surface of the cervix, classified as either mild (70% of cases fall into this category; the cells regress on their own), moderate, or severe, or as class 1, 2 or 3. While dysplasia itself does not cause health problems, it is considered to be a precancerous condition. Left untreated, dysplasia sometimes progresses to an early form of cancer known as cervical carcinoma in situ, and eventually to invasive cervical cancer.
(IV): A small needle placed in the vein to assist in fluid replacement or the giving of medication.
Malignant growth of epithelial cells tending to infiltrate the surrounding tissue and giving rise to metastasis.
Excision of tissue from a living being for diagnosis.
An infection, often recurrent, caused by herpes virus type 1 and 2. It causes cold sores around the lips and mouth, and also causes painful blisters on the genitals and in the pubic area, thighs, and buttocks.
Any of a vast group of minute structures composed of a protein coat and a core of DNA and/or RNA that reproduces in the cells of the infected host. Capable of infecting all animals and plants, causing devastating disease in immunocompromised individuals. Viruses are not affected by antibiotics, and are completely dependent upon the cells of the infected host for the ability to reproduce.
Refers to the various types of malignant neoplasms that contain cells growing out of control and invading adjacent tissues, which may metastasize to distant tissues.
Abnormal tissue that is not yet malignant.